Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Ultrasound contrast agent
Patent
1995-06-06
1998-01-13
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Ultrasound contrast agent
12866202, A61B 813
Patent
active
057076065
ABSTRACT:
Disclosed herein are agents for enhancing the contrast in a diagnostic ultrasound procedure. These agents comprise colloidal dispersions of the liquid-in-liquid type, i.e., emulsions or microemulsions, in which the dispersed liquid phase has a boiling point at or below the body temperature of the organism to be studied and thus undergoes a phase change from a dispersed liquid to a highly echogenic dispersed gaseous foam or kugelschaum following administration to an organism. The liquid state of the dispersed phase allows one to manufacture extremely stable, pharmaceutically acceptable emulsions with particle sizes typically below 1000 nm. The gaseous state at body temperature yields highly echogenic microbubbles, typically below 10,000 nm in diameter, which are effective as ultrasound contrast agents. Intravenous, intraarterial, oral, intraperitoneal, and intrauterine dosage forms, methods of administration, and imaging techniques are described.
REFERENCES:
patent: 3898843 (1975-08-01), Chabert et al.
patent: 4265251 (1981-05-01), Tickner et al.
patent: 4276885 (1981-07-01), Tickner et al.
patent: 4442843 (1984-04-01), Rasor et al.
patent: 4466442 (1984-08-01), Hilmann et al.
patent: 4533254 (1985-08-01), Cooke et al.
patent: 4544545 (1985-10-01), Ryan et al.
patent: 4572203 (1986-02-01), Feinstein
patent: 4657756 (1987-04-01), Rasor et al.
patent: 4681119 (1987-07-01), Rasor et al.
patent: 4684479 (1987-08-01), D'Arrigo
patent: 4718433 (1988-01-01), Feinstein
patent: 4767610 (1988-08-01), Long
patent: 4774958 (1988-10-01), Feinstein
patent: 4832941 (1989-05-01), Berwing et al.
patent: 4844882 (1989-07-01), Widder et al.
patent: 4859363 (1989-08-01), Davis et al.
patent: 4865836 (1989-09-01), Long
patent: 4895876 (1990-01-01), Schweighardt et al.
patent: 4900540 (1990-02-01), Ryan et al.
patent: 4927623 (1990-05-01), Long
patent: 4957656 (1990-09-01), Cerny et al.
patent: 4987154 (1991-01-01), Long
patent: 4993415 (1991-02-01), Long
patent: 5078146 (1992-01-01), Sato
patent: 5080885 (1992-01-01), Long
patent: 5088499 (1992-02-01), Unger
patent: 5107842 (1992-04-01), Levine et al.
patent: 5114703 (1992-05-01), Wolf et al.
patent: 5123414 (1992-06-01), Unger
patent: 5137928 (1992-08-01), Erbel et al.
patent: 5141738 (1992-08-01), Rasor et al.
patent: 5147631 (1992-09-01), Glagch et al.
patent: 5155215 (1992-10-01), Ranney
patent: 5171755 (1992-12-01), Kaufman
patent: 5205290 (1993-04-01), Unger
patent: 5260496 (1993-11-01), Meinert et al.
patent: 5271928 (1993-12-01), Schneider et al.
patent: 5281408 (1994-01-01), Unger
patent: 5284645 (1994-02-01), Long
patent: 5344930 (1994-09-01), Riess et al.
patent: 5354549 (1994-10-01), Klaveness et al.
patent: 5385147 (1995-01-01), Anderson et al.
patent: 5393513 (1995-02-01), Long, Jr.
patent: 5401493 (1995-03-01), Lohrmann et al.
patent: 5403575 (1995-04-01), Kaufman et al.
patent: 5406950 (1995-04-01), Brandenburger et al.
patent: 5409688 (1995-04-01), Quay
patent: 5413774 (1995-05-01), Schneider et al.
patent: 5505932 (1996-04-01), Grinstaff et al.
patent: 5536489 (1996-07-01), Lohrmann et al.
patent: 5536490 (1996-07-01), Klaveness et al.
patent: 5540909 (1996-07-01), Schutt
American Heart Association, Abstracts of the 58th Scientific Sessions, Circulation 72: Oct. 1985 III-427.
Association of University Radiologists, Proceedings of the Association of University Radiologists Annual Meeting 1982, Journal of Clinical and Laboratory Research Investigative Radiology 17:4, PS28, Abstract 110 (Jul.-Aug. 1982).
Bleeker, et al., On the Application of Ultrasonic Contrast Agents for Blood Flowmetry and Assessment of Cardiac Perfusion, Journal of Ultrasound in Medicine 9:461-471, 1990.
Bleeker, et al., Ultrasonic Characterization of Albunex, A New Contrast Agent, Journal Acoustical Society of America 87:1792-1797 (1990).
Davis, et al., Echogenicity Cause by Stable Microbubbles in a Protein-Lipid Emulsion, The Journal of Clinical Ultrasound 9:249-252, Jun., 1981.
De Jong, et al., Absorption and Scatter of Encapsulated Gas Filled Microspheres: Theoretical Consideration and Some Measurements, Ultrasonics 30:95-103 (1992).
De Jong, et al., Principles and Recent Developments in Ultrasound Contrast Agents, Ultrasonics 29:324-330 (Jul., 1991).
Epstein, et al., On the Stability of Gas Bubbles in Liquid-Gas Solutions, Journal of Chemical Physics 18:1505-1509 (Nov., 1950).
Feinstein, et al., Safety and Efficacy of a New Transpulmonary Ultrasound Contrast Agent: Initial Multicenter Clinical Results, Journal of American College of Cardiology 16:316-24 (Aug., 1990).
Feinstein, et al., Microcardial Contrast Echocardiography: Examination of Infracoronary Injections. Microbubble Diameters and Video Intensity Decay, American Journal of Physiologic Imaging 1:12-18 (1986).
Fobbe, et al., Farbkodierte Duplexsonographie Und Ultraschallkontrastimittel-Nachweis Von Renalen Perfusionsdefekten Im Tierexperiment, Fortschr. Rontgenstr. 154:242-245 (1991).
Handa, et al., Phospholipid Monolayers at the Triolein-Saline Interface: Production of Microemulsion Particles and Conversion of Monolayers to Bilayers, Biochemistry 29:2884-2890 (1990).
Kabalnov, et al., Safety and Efficacy of a New Transpulmonary Ultrasound Contrast Agent: Initial Multicenter Clinical Results, Journal of Fluorine Chemistry 50:271-284 (1990).
Keller, et al., Successful Left Ventricular Opacification Following Peripheral Venou Injection of Sonicated Contrast Agent: An Experimental Evaluation, American Heart Journal, 115:4:570-575 (Sep. 1987).
Long, et al., Experiments With Radiopaque Perfluorocarbon Emulsions for Selective Opacification of Organs and Total Body Angiography, Investigative Radiology 15:242-247 (1980).
Marshall, Encyclopedie Des Gaz, Encyclopedia of Gas, 1976.
Mattrey, et al., Gas Emulsions as Ultrasound Contrast Agents Preliminary Results in Rabbits and Dogs, Investigative Radiology, 29: S139-S141 (Jun. Supplement 1994).
Meltzer, et al., Transmission of Ultrasonic Contrast Through the Lungs, Ultrasound in Med. & Biol., vol. 7, No.4, pp. 377-384 (1981).
Meltzer, et al., Why do the Lungs Clear Ultrasonic Contrast? Ultrasound in Medicine and Biology 6:263-269 (1980).
Ohta, et al. Effect of the Contrast Agent and the Agitation Method on the Size, Number and Stability of Microbubbles: A Basic Experiment for the Myocardial Contrast Study, Japanese Journal of Medical Ultrasonics 18:318-325 (1991).
Ophir, et al., Contrast Agents in Diagnostic Ultrasound, Ultrasound in Medicine and Biology, 15:319-333 (1989).
Schubert, et al., Microemulsifying Fluorinated Oils With Mixtures of Fluorinated and Hydrogenated Surfactants, Colloids and Surfaces: Physicochemical and Engineering Aspects 84:97-106 (1994) (submitted as a communication).
Schlief, Ultrasound Contrast Agents, Current Opinion in Radiology 3:198-207 (1991).
Serratrice, et al., Co-Solubilisation De Fluorocabures Et D'Eau En Presence De Nouveaux Tensioactifs Non Ioniques Fluores, Journal Chim. Phys. 87:1969-1980 (1990).
Swanson, et al., Pharmaceuticals in Medical Imaging; Radiopaque Contrast Media Radiopharmaceuticals Enhancement Agents for Magnetic Resonance Imaging and Ultrasound, Macmillan Publishing Co., Inc., pp. 682-685 (1990).
Szonyi, et al., Syntheses De Tensioactifs F-Alkyles Non Ioniques Monodisperses, Journal of Fluorine Chemistry 36:195-209 (1987).
Verescon, et al., An Easy, Convenient Way of Describing the Stability of Fluorocarbon Emulsions, Journal of de Chimie Physique 86:2111-2116 (1989).
Violante, et al., Particle Stabilized Bubbles for Enhanced Organ Ultrasound Imaging, Investigative Radiology 26:194-200 (Nov., 1991).
Widder, et al., Microbubbles as a Contrast Agent for Neurosonography and Ultrasound-Guided Catheter Manipulation: In Vitro Studies, AJR 147:347-352 (Aug. 1986).
Zarif, et al., Synergistic Stabilization of Perfluorocarbon-Pluronic F-68 Emulsion by Perfluoroalkylated Polyhydroxylated Surfactants, Jaocks 66:10 (Oct. 1989).
Ziskin, et al., Contrast Agents for Diagnostic Ultrasound, Investigative Radiology 6:500-505 (1972).
Hollinden Gary E.
Sonus Pharmaceuticals Inc.
LandOfFree
Phase shift colloids as ultrasound contrast agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phase shift colloids as ultrasound contrast agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phase shift colloids as ultrasound contrast agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-323974